Showing 1 to 1 of 1 results
theguardian.com
🌐 85% Global Worthiness
Non-Hormonal Male Contraceptive Shows 24-Month Efficacy in Phase 1 Trial
Contraline's Adam, a non-hormonal male contraceptive hydrogel implant, successfully blocked sperm release for 24 months in a phase 1 trial of 25 men, with no serious side effects reported; further trials are planned to assess reversibility.
Non-Hormonal Male Contraceptive Shows 24-Month Efficacy in Phase 1 Trial
Contraline's Adam, a non-hormonal male contraceptive hydrogel implant, successfully blocked sperm release for 24 months in a phase 1 trial of 25 men, with no serious side effects reported; further trials are planned to assess reversibility.
Progress
52% Bias Score
Gender Equality
Showing 1 to 1 of 1 results